In this study, we aimed to investigate the effects of oral treatment with a water-based GCE on atherosclerosis and a set of CMS features that are known to increase cardiovascular risk using HFD-fed ApoE-/- mice as a model. The gene discussed is APOE; the disease is atherosclerosis.